Clinical Effectiveness of a Newly Developed Collagen Substitute (InsureGraf®)
Journal of Korean Burn Society
;
: 12-15, 2017.
Article
in Korean
| WPRIM
| ID: wpr-167672
ABSTRACT
PURPOSE:
Aim of this study was to assess effects of InsureGraf® (SK-Bioland Co., Korea), an artificial dermis developed by using tissue engineering technology in severe burn patients.METHODS:
To examine the clinical effectiveness of InsureGraf®, we transplanted them in patients with severe burns. A total of 14 joint regions in 8 patients received InsureGraf® graft selectively from July to December, 2014. The graft results were determined after confirming the take rate of the transplanted skin graft on top of the InsureGraf®. Take rates were examined twice, at 7 and 14 days after grafting. Photographs of the skin grafts were evaluated individually by two burn surgeon specialists, and the mean values were recorded.RESULTS:
The take rate was 99% after day 7 and 100% after day 14 respectively.CONCLUSION:
InsureGraf® can be used successfully as an artificial dermis that allows one-stage operation in severe burn patients, exhibiting a successful early-stage graft take rate that is close to 100%.
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Skin
/
Specialization
/
Burns
/
Collagen
/
Treatment Outcome
/
Transplants
/
Dermis
/
Tissue Engineering
/
Joints
Limits:
Humans
Language:
Korean
Journal:
Journal of Korean Burn Society
Year:
2017
Type:
Article
Similar
MEDLINE
...
LILACS
LIS